Isolation and in vitro maturation of immature oocytes from ovarian tissue in fertility preservation treatments.

Not Applicable

Completed

• Conditions: Procreative management; Z31; Other medical care; Z51

• Registration Number: DRKS00013170
• Lead Sponsor: niversitätsklinikum Heidelberg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-12-11
• Study Completion: 2020-06-06
• Results First Posted: 2020-06-17
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

Patients whose ovarian tissue is cryopreserved for fertility preservation.
Patients and partners able to provide informed consent.
Firm relationship.
Age of the patient 18-43 years.
Age of the partner from 18 years.

Exclusion Criteria

postmenopausal patients,
patients under age,
partners under age,
patients without firm relationship

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Isolation of immature oocytes from ovarian tissue

Secondary Outcome Measures

Name	Time	Method
in vitro maturation rate,<br>vitality,<br>fertilisation rate,<br>clinical outcomes after in-vitro culture and embryo transfer